Cite
Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial.
MLA
Scheltema, Nienke M., et al. “Respiratory Syncytial Virus Prevention and Asthma in Healthy Preterm Infants: A Randomised Controlled Trial.” The Lancet. Respiratory Medicine, vol. 6, no. 4, Apr. 2018, pp. 257–64. EBSCOhost, https://doi.org/10.1016/S2213-2600(18)30055-9.
APA
Scheltema, N. M., Nibbelke, E. E., Pouw, J., Blanken, M. O., Rovers, M. M., Naaktgeboren, C. A., Mazur, N. I., Wildenbeest, J. G., van der Ent, C. K., & Bont, L. J. (2018). Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial. The Lancet. Respiratory Medicine, 6(4), 257–264. https://doi.org/10.1016/S2213-2600(18)30055-9
Chicago
Scheltema, Nienke M, Elisabeth E Nibbelke, Juliëtte Pouw, Maarten O Blanken, Maroeska M Rovers, Christiana A Naaktgeboren, Natalie I Mazur, Joanne G Wildenbeest, Cornelis K van der Ent, and Louis J Bont. 2018. “Respiratory Syncytial Virus Prevention and Asthma in Healthy Preterm Infants: A Randomised Controlled Trial.” The Lancet. Respiratory Medicine 6 (4): 257–64. doi:10.1016/S2213-2600(18)30055-9.